Detection and Characterization of Circulating Microsatellite‐DNA in Blood of Patients with Breast Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1196/annals.1318.005PMID 15251935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

  2004cited by this paper
• A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis

  2003cited by this paper
• Tumor suppressor gene E-cadherin and its role in normal and malignant cells

  2003cited by this paper
• Microsatellite analysis of breast carcinoma and corresponding local recurrences

  2002cited by this paper
• Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

  2002cited by this paper
• Persistence of tumor DNA in plasma of breast cancer patients after mastectomy

  2002cited by this paper
• Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

  2000cited by this paper
• A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.

  2000cited by this paper
• Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

  1999cited by this paper
• BRCA1-associated growth arrest is RB-dependent.

  1999cited by this paper
• Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma

  1999cited by this paper
• Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.

  1999cited by this paper
• Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.

  1999cited by this paper
• Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.

  1999cited by this paper
• Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.

  1998cited by this paper
• Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.

  1997cited by this paper
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Microsatellite alterations in serum DNA of head and neck cancer patients

  1996cited by this paper
• Microsatellite alterations in plasma DNA of small cell lung cancer patients

  1996cited by this paper
• High frequency of allelic imbalance at chromosome region 16q22‐23 in human breast cancer: Correlation with high pgr and low s phase

  1995cited by this paper
• Cancer statistics, 1995

  1995cited by this paper
• Detailed deletion mapping of chromosome segment 17q12‐21 in sporadic breast tumours

  1994cited by this paper
• High-density genetic map of the BRCA1 region of chromosome 17q12-q21.

  1993cited by this paper
• Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

  1990cited by this paper
• Neoplastic characteristics of the DNA found in the plasma of cancer patients.

  1989cited by this paper
• Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease

  1983cited by this paper
• Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

  1983cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper

• Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer

  2022cites this paper
• Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

  2020cites this paper
• Evaluation of TAGLN as a diagnostic marker in breast cancer

  2018cites this paper
• A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA

  2018cites this paper
• Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer

  2017cites this paper
• Breast Cancer Biomarkers in Circulation

  2017cites this paper
• Circulating nucleic acids: An analysis of their occurrence in malignancies.

  2016cites this paper
• Cell-free DNA as a diagnostic marker for cancer: current insights

  2016cites this paper
• Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection

  2015cites this paper
• Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer

  2013cites this paper
• Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology

  2013cites this paper
• Hide and seek: tell-tale signs of breast cancer lurking in the blood

  2012cites this paper
• Circulating DNA-Important Biomarker of Cancer

  2012cites this paper
• Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer

  2011cites this paper
• Oncoproteins and Early Tumor Detection

  2011cites this paper
• Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

  2011cites this paper
• Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.

  2011cites this paper
• Biomarkers in cancer micrometastasis: where are we at?

  2010cites this paper
• Intraductal Approaches: Nipple Aspirate Fluid to Assist in Breast Cancer Detection

  2010cites this paper
• Molecular Diagnostics in the Evaluation of Cancer

  2010cites this paper
• Quantificazione del DNA sierico mediante "real time polymerase chain reac- tion" in pazienti affetti da polipi e da cancro del colon-retto*

  2010cites this paper
• Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

  2010cites this paper
• Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease

  2010cites this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cites this paper
• Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?

  2010cites this paper
• Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

  2009cites this paper
• Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

  2009cites this paper
• Breast cancer screening and biomarkers.

  2009cites this paper
• Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

  2009cites this paper
• Analyse der freien zirkulierenden DNA von Prostatakarzinom-Patienten auf allelische Imbalance

  2009cites this paper
• The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

  2009cites this paper
• Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer

  2008cites this paper
• Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer?

  2008cites this paper
• Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

  2008cites this paper
• Applications of free circulating nucleic acids in clinical medicine: recent advances.

  2008cites this paper
• Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer

  2008cites this paper
• Breast Cancer Patients: Diagnostic Epigenetic Markers in Blood

  2008cites this paper
• Molecular Assessment of Sentinel Lymph Nodes

  2008cites this paper
• 'Other' applications of single nucleotide polymorphisms.

  2007cites this paper
• Microsatellite Analysis in Serum DNA as a Diagnostic Tool for Distinction of Patients With Unknown Pancreatic Masses

  2007cites this paper
• A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

  2007cites this paper
• Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer

  2007cites this paper
• Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasia.

  2007cites this paper
• Circulating nucleic acids in plasma/serum

  2007cites this paper
• Circulating tumor cells: detection, molecular profiling and future prospects

  2007cites this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007cites this paper
• Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer.

  2007cites this paper
• Biomarkers for early detection of breast cancer: what, when, and where?

  2007cites this paper
• Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.

  2007cites this paper
• Caracterização genética de populações de campo de Schistosoma mansoni com o uso de microssatélites.

  2007cites this paper
• Comparison of Genetic Alterations Detected in Circulating Microsatellite DNA in Blood Plasma Samples of Patients with Prostate Cancer and Benign Prostatic Hyperplasia

  2006cites this paper
• Epigenetic Analysis of Body Fluids and Tumor Tissues

  2006cites this paper
• Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer

  2006cites this paper
• Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluids

  2006cites this paper
• Analysis of nipple aspirate fluid for diagnosis of breast cancer: an alternative to invasive biopsy

  2005cites this paper
• Circulating nucleic acids : An analysis of their occurrence in malignancies ( Review )

  year unknowncites this paper